Authors' reply to the comment "Treatment considerations for patients with pemphigus during the COVID-19 pandemic".
作者信息
Shakshouk Hadir, Daneshpazhooh Maryam, Murrell Dedee F, Lehman Julia S
机构信息
Department of Dermatology, Mayo Clinic, Rochester, Minnesota; Department of Dermatology, Andrology and Venereology, Alexandria University, Egypt.
Department of Dermatology, Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Iran.
出版信息
J Am Acad Dermatol. 2021 Jan;84(1):e61-e62. doi: 10.1016/j.jaad.2020.09.002. Epub 2020 Sep 4.
Abstract
摘要
相似文献
1
Authors' reply to the comment "Treatment considerations for patients with pemphigus during the COVID-19 pandemic".作者对评论“COVID-19大流行期间天疱疮患者的治疗考量”的回复
J Am Acad Dermatol. 2021 Jan;84(1):e61-e62. doi: 10.1016/j.jaad.2020.09.002. Epub 2020 Sep 4.
2
Reply to "Treatment considerations for patients with pemphigus during the COVID-19 pandemic".对《COVID-19大流行期间天疱疮患者的治疗考量》的回复
J Am Acad Dermatol. 2021 Jan;84(1):e59-e60. doi: 10.1016/j.jaad.2020.07.132. Epub 2020 Sep 4.
3
Treatment considerations for patients with pemphigus during the COVID-19 pandemic.COVID-19大流行期间天疱疮患者的治疗考量
J Am Acad Dermatol. 2020 Jun;82(6):e235-e236. doi: 10.1016/j.jaad.2020.04.005. Epub 2020 Apr 10.
4
Authors' Reply to: COVID-19 as a "Force Majeure" for Non-COVID-19 Clinical and Translational Research. Comment on "Analysis of Scientific Publications During the Early Phase of the COVID-19 Pandemic: Topic Modeling Study".作者对《将2019冠状病毒病视为非2019冠状病毒病临床及转化研究的“不可抗力”》的回复。对《2019冠状病毒病大流行早期科学出版物分析：主题建模研究》的评论
J Med Internet Res. 2021 May 20;23(5):e29156. doi: 10.2196/29156.
5
COVID-19 severity and SARS-Cov-2 vaccine safety in pemphigus patients.天疱疮患者的 COVID-19 严重程度和 SARS-CoV-2 疫苗安全性。
Dermatol Ther. 2022 May;35(5):e15417. doi: 10.1111/dth.15417. Epub 2022 Mar 10.
6
Authors' reply to: Comment on the article by Dr. N. Shakrawal: Barrier device prototype for open tracheotomy during COVID-19 pandemic.作者对以下内容的回复：对N. Shakrawal博士文章《COVID-19大流行期间开放性气管切开术的屏障装置原型》的评论
Auris Nasus Larynx. 2021 Feb;48(1):177. doi: 10.1016/j.anl.2020.10.013. Epub 2020 Oct 26.
7
Estimating the susceptibility to SARS-CoV-2 infection with rituximab use for pemphigus vulgaris.评估使用利妥昔单抗治疗寻常型天疱疮患者对 SARS-CoV-2 感染的易感性。
J Dermatolog Treat. 2022 May;33(3):1606-1607. doi: 10.1080/09546634.2020.1870648. Epub 2021 Jan 12.
8
Authors' Reply to: Redundancy of Terms in Search Strategies. Comment on "Searching PubMed to Retrieve Publications on the COVID-19 Pandemic: Comparative Analysis of Search Strings".作者对《检索策略中术语的冗余性》的回复。对《在PubMed中检索关于COVID-19大流行的出版物：检索词的比较分析》的评论。
J Med Internet Res. 2021 May 28;23(5):e29507. doi: 10.2196/29507.
9
Rituximab as the treatment of pemphigus vulgaris in the COVID-19 pandemic era: A narrative review.在 COVID-19 大流行期间用利妥昔单抗治疗寻常型天疱疮：一项叙述性综述。
Dermatol Ther. 2021 Jan;34(1):e14405. doi: 10.1111/dth.14405. Epub 2020 Oct 20.
10
Authors' reply to: Comment on the article by Dr. T.Huda: Barrier device prototype for open tracheotomy during COVID-19 pandemic.作者对以下评论的回复：对T.胡达博士文章《COVID-19大流行期间开放式气管切开术的屏障装置原型》的评论
Auris Nasus Larynx. 2020 Aug;47(4):713. doi: 10.1016/j.anl.2020.07.015. Epub 2020 Jul 17.
引用本文的文献
1
Adverse outcome and severity of COVID-19 in patients with autoimmune bullous diseases: A historical cohort study.自身免疫性大疱性疾病患者 COVID-19 的不良结局和严重程度：一项历史性队列研究。
Dermatol Ther. 2022 Sep;35(9):e15672. doi: 10.1111/dth.15672. Epub 2022 Jul 21.
2
Considerations on Immunization and Immunosuppression of Patients With Autoimmune Blistering Diseases During COVID-19 Pandemic in Brazil: Case Report.巴西新冠疫情期间自身免疫性水疱病患者免疫接种与免疫抑制的考量：病例报告
Front Med (Lausanne). 2022 Apr 12;8:811562. doi: 10.3389/fmed.2021.811562. eCollection 2021.
3
Impact of COVID-19 on autoimmune blistering diseases.COVID-19 对自身免疫性水疱病的影响。
Clin Dermatol. 2021 May-Jun;39(3):359-368. doi: 10.1016/j.clindermatol.2021.01.007. Epub 2021 Feb 2.
本文引用的文献
1
Rituximab: a safe therapeutic option during the COVID-19 pandemic?
J Dermatolog Treat. 2022 Mar;33(2):1197. doi: 10.1080/09546634.2020.1800565. Epub 2020 Jul 29.
2
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases.COVID-19 疫苗接种准备与自身免疫性疾病中的抗 CD20 耗竭疗法。
Clin Exp Immunol. 2020 Nov;202(2):149-161. doi: 10.1111/cei.13495. Epub 2020 Aug 1.
3
Dexamethasone in the management of covid -19.地塞米松在新冠病毒病治疗中的应用
BMJ. 2020 Jul 3;370:m2648. doi: 10.1136/bmj.m2648.
4
Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.2019冠状病毒病大流行期间自身免疫性大疱性疾病管理的专家建议。
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e302-e303. doi: 10.1111/jdv.16525. Epub 2020 Jun 4.
5
Treatment considerations for patients with pemphigus during the COVID-19 pandemic.COVID-19大流行期间天疱疮患者的治疗考量
J Am Acad Dermatol. 2020 Jun;82(6):e235-e236. doi: 10.1016/j.jaad.2020.04.005. Epub 2020 Apr 10.
Zotero 插件